Martin Doane, Chief Executive Officer of Garmatex Technologies, Inc. says that Garmatex’s non-brokered private placement to raise up to $15 million, which is underway, and its goal of conducting an IPO in the near-term, will assist his research and development-oriented fabric manufacturing company’s goal of becoming “the Apple of the fabric world.” 

Doane made these remarks today as Vancouver-based Garmatex completes its eighth year of operation, with solutions developed for the sport, sleepwear, occupational health and safety and medical sectors. “Ever since we re-positioned ourselves 18 months ago as a textiles manufacturer rather than just a sport and lifestyle garment manufacturer, the scope of our growth has been explosive,” he says.

“Our momentum is building towards an anticipated IPO and further capital raises, with the proceeds geared towards boosting our manufacturing, sales and marketing capabilities”, says Doane.  

Garmatex’s fabrics, designs and technologies, branded as Kottinu, CoolSkin, WarmSkin, Satinu, ColdSkin, T3, Bact-Out, SteelSkin, SlimSkin, CamoSkin, RecoverySkin and AbsorbSkin provide best-in-class temperature and moisture management performance, resilience, bacteria-repelling properties and comfort.

Garmatex fabric is unique because the company’s research and development team has redefined the foundation of microfiber filament construction.  Garmatex also controls the manufacturing process from the raw grain stage, through filament extrusion, knitting or weaving, and dyeing and setting.

Garmatex’s ability to manipulate its man-made fiber on a molecular level to suit different end uses means it can develop solutions for a wide variety of clients. To date it has created everything from a high-performance alternative to cotton undergarment fabric worn by firefighters, to sleepwear that keeps users cool at night.

Doane points out that his company’s versatility “enables us to be a solutions provider to clients in sectors as diverse as medicine, law enforcement, automotive, hospitality – you name it.” Garmatex’s research and development team mixes and matches hundreds of microfiber filaments and experiments with different knitting techniques and anti-bacterial processes to engineer solutions for clients.

Better still, because Garmatex works directly with clients to develop end product, the traditional costly and time-consuming practice of procuring fabric through overseas intermediaries is eliminated. “We’re changing the fabric market terrain in many fundamental ways, and the big winner is the client,” says Doane.

Doane, who is also Founder and Chairman of Ubequity Capital Partners, is excited about Garmatex’s growth in 2014. “I haven’t come across a company with such explosive potential in a long time,” he says. “I truly believe we’re on our way to achieving our goal of becoming the Apple of the fabric world.”